Latest News

Intravenously administered ketamine shown to reduce symptoms of chronic post-traumatic stress disorder

For the first time, evidence that a single dose of IV-administered ketamine was associated with the rapid reduction of symptoms of post-traumatic stress disorder in patients with chronic PTSD was demonstrated in a proof-of-concept, randomized, double blind crossover study. These findings could be the first step toward developing new interventions for PTSD.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Why do challenging tasks make consumers believe drugs wear off faster?

  • Empathy or justice: What makes consumers donate more to charity?

  • I?ll have what he's having? How consumers make choices about new products

  • Retail pricing strategies: Do consumers prefer Deep Discounts or Everyday Low Prices?

  • Clients of violence interventional advocacy program find experience supportive

  • Potential Genetic Link Between Epilepsy, Neurodegenerative Disorders

  • Lacking trust in one's doctor affects health of emotionally vulnerable cancer patients

  • Dopamine transporter: Stampede supercomputer used to study common link between addiction, neurological disease

  • Should you should talk to strangers? Doing so increases positive experience, study shows

  • Genetic dysfunction connected to hydrocephalus discovered by international research team

  •